Follow up in regards to previous post: "A blockbuster cocktail?"
The real story regarding Phenex Pharma (a private company) is they were not bought out by Gilead as the article suggests. Phenex Pharma maybe did one better. They effectively sold their drug/development candidate for $470M US$. To my knowledge cilofexor (FXR agonist PX20606) reduced fibrosis by 43% (see link below). Barely half as much as Algernon's 84.4% result. Here's what Phenex Pharma had to say about thier bought deal(s):
In addition, the widely accepted STAM™ mouse model from SMC Laboratories used by Algernon Pharmaceuticals is also used by Phenex Pharma.